Navigation Links


Neutropenia in Medical Technology

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... (NCI Grades 3/4) lab abnormalities-including neutropenia (3.6%-48%), anemia (1%-42%), thrombocytopenia ... included anemia (17%), thrombocytopenia (17%), neutropenia (8%), and increased creatinine (8%). In ... abnormalities (400 mg/day; 600 mg/day)--including neutropenia (10%; 11%), anemia (3%; 9%), thrombocytopenia ...

Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer

... toxicities and infections, including: - neutropenia - 66% (Grade 3/4 57%) versus 65% (Grade 3/4 59%), with febrile neutropenia reported in 7% versus 6% of patients - ... neutrophil count, hemoglobin level, or neutropenia with fever) may require dose reduction, delay in ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), ... toxicity, most commonly thrombocytopenia (5%) and neutropenia (3%). A total of 50% of patients experienced ... respectively, were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral ...

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%), and hyperglycemia ... adverse reactions were thrombocytopenia (37%), neutropenia (37%), anemia (23%), and elevated lipase (17%). ... (NCI Grades 3/4) lab abnormalities -- including neutropenia (3.6%-48%), anemia (1%-42%), thrombocytopenia ( ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), ... most commonly thrombocytopenia (5%) and neutropenia (3%). A total of 50% of patients experienced ... were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral ...

CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors

... and adverse events were combined, Grade 3 or 4 neutropenia occurred in 8% and Grade 3 or 4 platelet ... 9.5% of patients over age 70 experienced Grade 4 neutropenia or thrombocytopenia in the first cycle, ... equal to age 70, 7% and 5.5% experienced Grade 4 neutropenia or thrombocytopenia in the first cycle, ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... (NCI Grades 3/4) lab abnormalities -- including neutropenia (3.6%-48%), anemia (1%-42%), thrombocytopenia ... adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%) and hyperglycemia ... adverse reactions were thrombocytopenia (37%), neutropenia (37%), anemia (23%) and elevated lipase (17%). ...

Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkin's Lymphoma

... CHOP-R related toxicities included grade 3 to 4 neutropenia occurred in 23 (39%) patients and grade 3 to 4 ... with Zevalin was myelosuppression. Grade 3 to 4 neutropenia occurred in 28 (51%) of patients with one incidence of febrile neutropenia requiring hospitalization. Grade 3 to 4 ...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

... (NCI Grades 3/4) lab abnormalities--including neutropenia (3.6%-48%), anemia (1%-42%), thrombocytopenia ... included anemia (17%), thrombocytopenia (17%), neutropenia (8%) and increased creatinine (8%). In GIST, ... abnormalities (400 mg/day; 600 mg/day)--including neutropenia (10%; 11%), anemia (3%; 9%), thrombocytopenia ...

Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments

... The most commonly reported adverse events were neutropenia and mouth sores. "These preliminary results are ... Grade 2 and 3 mouth sores and grade 3 and 4 neutropenia were seen. Among 11 patients evaluated ... arm, grade 2 and 3 mouth sores and grade 3 and 4 neutropenia were seen. About breast cancer Breast cancer ...

Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... neutrophil count, hemoglobin level, or neutropenia with fever) may require dose reduction, delay in ... or hemorrhage -- Sepsis occurring during neutropenia has resulted in discontinuation of ... DOXIL vs VELCADE, respectively) included: neutropenia (36% vs 22%), thrombocytopenia (33% vs ...

Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent

... than or equal to grade 3 toxicities included neutropenia (11 patients) and thrombocytopenia (16 ... Reversible hematologic toxicities included neutropenia grade 4 in 5 patients and grade 3 in 13 patients. ... occurred in 16 of 20 patients with grade 3-4 neutropenia reported in 11 of 20 patients. Four patients ...

Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF

... met the safety criterion for duration of neutropenia (less than or equal to five days of severe neutropenia). In these trial conditions, severe neutropenia typically lasts approximately seven days ... $4 billion in 2006. About Neutropenia neutropenia is a severe decrease in neutrophil cell counts in ...

Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting

... neutrophil count, hemoglobin level, or neutropenia with fever) may require dose reduction, delay in ... or hemorrhage -- Sepsis occurring during neutropenia has resulted in discontinuation of ... plus DOXIL vs VELCADE, respectively) included: neutropenia (36% vs 22%), thrombocytopenia (33% vs 28%), ...

Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine

... cisplatin and fluorouracil arm (PF) had grade 3/4 neutropenia (76.9% vs. 52.5%), alopecia (11.6% vs. ... in the Taxotere-based regimen included febrile neutropenia (5.2%) and neutropenic infection (13.9%). The ... Patients treated with TPF had more febrile neutropenia (12% vs 7%), neutropenic infection (12% vs 8%), ...

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

... most common grade 3, 4 adverse event observed on the pixantrone arm was neutropenia in 41.2% of patients versus 19.4% on the comparator arm. However, the incidence of grade 3, 4 febrile neutropenia was only 7.4% versus 3.0% in the comparator arm. Grade 3, 4 infections ...

Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment

... most common grade 3, 4 adverse event observed on the pixantrone arm was neutropenia in 41.2% of patients versus 19.4% on the comparator arm. However, the incidence of grade 3, 4 febrile neutropenia was only 7.4% versus 3.0% in the comparator arm. Grade 3, 4 infections ...

Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer

... reactions were stomatitis (44% for IC+CRT vs. 31% for CRT) and febrile neutropenia (10% for IC+CRT vs. 1% for CRT). Other adverse events included neutropenia and asthenia. "These study results illustrate that this complex ...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

... Leukine data highlights include the following: Chemotherapy-Induced neutropenia Budget impact analysis of sargramostim use in patients with chemotherapy-induced neutropenia Lead investigator: M. Duh, Analysis Group, Inc., Boston, MA ...

Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer

... With regard to hematologic toxicities, thrombocytopenia and neutropenia were more frequent and severe with the FOLPI regimen compared with FOLFOX. However, only one episode of febrile neutropenia and no bleeding complications have been observed to date. In addition, 83 ...

InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)

... by the investigator to be unrelated to ITMN-191. The other two were neutropenia and indirect bilirubin elevation. neutropenia occurred with a similar pattern, frequency and severity in the placebo and ...

Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer

... fatigue (50 percent), diarrhea (27 percent), nausea, anorexia, and neutropenia (all 23 percent), vomiting and dizziness (18 percent). The most common Grade 3/4 toxicity was neutropenia (23 percent) and was the only Grade 3/4 adverse event that occurred in ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... (21%), cough and insomnia (each 20%), rash (18%), arthralgia (17%), neutropenia and dizziness (excluding vertigo) (each 17%), pain in limb and abdominal ... with MP vs MP, respectively, were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), ...

New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients

... with MP vs MP, respectively, were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), ... than or equal to Grade 4 toxicity, most commonly thrombocytopenia (5%) and neutropenia (3%). A total of 50% of patients experienced serious adverse events (SAEs) ...

Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting

... 3-5 adverse events, regardless of relation to treatment, were febrile neutropenia in 8 patients, and neutropenia and thrombocytopenia in 7 patients respectively. One patient died within ...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... pill and could theoretically reduce its effectiveness. -- Severe neutropenia [absolute neutrophil count (ANC) cardiac, and up to 3.6% of ... Patients receiving CellCept should be monitored for neutropenia. If neutropenia develops (ANC dosing with CellCept should be interrupted or the dose ...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

... pill and could theoretically reduce its effectiveness. -- Severe neutropenia [absolute neutrophil count (ANC) 10cubed/microL] developed in up to ... Patients receiving CellCept should be monitored for neutropenia. If neutropenia develops (ANC CellCept should be interrupted or the dose reduced, ...

New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data

... Oncology, Hospital Saint Antoine, Paris, France. In the MOSAIC trial, neutropenia (decrease in the number of white blood cells) was the most frequently reported side effect, affecting 78.9% of patients. neutropenia was complicated by fever or infection in only 1.8% of cases. Peripheral ...

Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market

... for the European market. The market launch is planned for early 2010. neutropenia - a condition whereby the concentration of neutrophils (a type of white ... colony stimulating factor (G-CSF) is a human protein that can reverse neutropenia by initiating the production of neutrophils. Recombinant forms of the ...

Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

... or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with ... hypokalemia (31.3%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed ...

MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule

... or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with ... hypokalemia (31.3%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed ...

Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme

... trials to have a higher risk of developing myelosuppression. Grade 3/4 neutropenia (lab and AE combined) occurred in eight percent and Grade 3/4 ... treated with temozolomide. In refractory anaplastic astrocytoma, Grade 3/4 neutropenia occurred in 14 percent and Grade 3/4 thrombocytopenia occurred in 19 ...

Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery

... and fluorouracil (PF). Patients treated with TPF had more febrile neutropenia (12% vs 7%), neutropenic infection (12% vs 8%), and grade 3/4 neutropenia (84% vs. 56%), dizziness (4% vs. 2%), alopecia (4% vs 1%) and diarrhea (7% ...

Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes

... leukopenia (16%); anemia (6%); thrombocytopenia (5%); infection without neutropenia (2%); fatigue (17%); thrombosis/embolism (6%); nausea (12%); vomiting ... (72%); chest pain (38%); neuropathy/sensory (29%); infection without neutropenia (23%); and rash (17%). See complete Warnings, Precautions, Adverse ...

Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer

... Anaemia, leucopenia, thrombocytopenia, neutropenia. Common: Febrile neutropenia and infection without neutropenia. Uncommon: Pancytopenia. ... associated with an increased incidence of infections. Fatigue and febrile neutropenia also occur more frequently with this combination. Administration site ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... None of the patients in cohort one had an initial dose-limiting toxicity (IDLT) with two cycles of therapy. There was one IDLT of infection with neutropenia in cohort two. Aside from grade 3 fatigue in two patients, there were no grade 3 or greater nonhematologic toxicities. A median of 4.5 cycles was ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... Had a Dose Reduction 2 3% 21 14% ---------------------- --- --- --- --- neutropenia (ANC less than 1500) 0 0% 3 2% -------------------------------- --- --- --- --- Diarrhea, ...

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

... a child while receiving treatment with Dacogen and for two months afterwards. The most commonly occurring adverse reactions with Dacogen include neutropenia (90 percent), thrombocytopenia (89 percent), anemia (82 percent), pyrexia (53 percent), fatigue (48 percent), nausea (42 percent), cough (40 ...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

... was well tolerated. The most commonly reported adverse events (grade 3 or 4; >10% patients) in this heavily pretreated population included anemia, neutropenia and thrombocytopenia(1). About non-Hodgkin's lymphoma and Hodgkin's disease Non-Hodgkin's lymphoma and Hodgkin's disease manifest in the ...

Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL

... regimens produced encouragingly high rates of overall response (58-74%) including high rates of complete responses (37-57%). As previously reported, neutropenia was the dose limiting toxicity when used as a single agent. "In both preclinical and early clinical studies pixantrone exhibited lower cardiac ...
Other Contentsnoninvasivenoninvasivenoninvasivenoninvasivenoninvasivenoninvasivedrugsdrugsdrugsdrugsdrugsdrugsdrugsdrugsdrugsdrugsnonsteroidalnonsteroidalnonunionnosebleedbleedsbleedstinglingtinglingnumbnessnumbnessnumbness
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
(Date:12/13/2009)... have discovered five genetic variants that are associated with ... an international consortium of 96 scientists from 63 centres ... molecular basis of lung diseases. , The new findings ... Chronic Obstructive Pulmonary Disease (COPD) and asthma. In the ... because the molecular pathways that affect the health of ...
(Date:12/11/2009)... for premium fruit increases, growers are being challenged ... to boost their bottom line, orchard owners are ... quality while reducing labor costs. , Hand thinning, ... larger, healthier fruit, is among the most labor-intensive ... fruit production overhead, and, ultimately, prices paid by ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3New genes for lung disease discovered 2Horizontal string trimmer reduces labor costs, increases peach size 2SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 1SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 2SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 3SunGard Availability Services Addresses the Business Operational and Workforce Issues Involved in Pandemic Planning 60100 4LABS Inc to Offer Donor Testing Services for Transfusion Medicine and Blood Services Industry 60097 1LABS Inc to Offer Donor Testing Services for Transfusion Medicine and Blood Services Industry 60097 2Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 1Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 2
(Date:12/16/2009)... American Podiatric Medical Association’s Seal of Acceptance , ... ... As shoppers continue their search for the perfect gift this ... items that are considered healthy for the environment. When it ... of today’s most stylish items are also healthy for feet—making ...
(Date:12/16/2009)... one-fourth the time it takes to obtain a bachelor degree, ... ophthalmic assistant. , ... (Vocus) December ... The National Report Card on Higher Education" by the National ... tuition have outpaced price increases in other sectors of the ...
(Date:12/16/2009)... Christmas rush Hallmark Cards have announced a great addition to ... an easy to navigate website at www.hallmark.co.uk/specialoccasions , customers can ... their own words and photos and then order as many copies ... ... Bradford, UK (PRWEB) December 16, 2009 -- Just in time ...
(Date:12/16/2009)... The holidays are rapidly approaching and what would be the perfect ... stem cells, of course! Celebrity Beauty Engineer® and Licensed Esthetician Mary ... how to look and feel their best! , ... ... what kind of gift does a person get that special woman ...
(Date:12/16/2009)... Instead of buying another product or thing for your loved ones ... them personal assistant services like housekeeping, errand running, child care, and ... ... (PRWEB) December 12, 2009 -- Residents of the Denver and Boulder ... year to their friends and loved ones by using Delegate Source,s ...
Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 2Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 3Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 5Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 2Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 3Health News:The UK's Biggest Card Retailer Takes Choice and Value Personally 4Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 2Health News:Give the Gift of Service This Holiday Season with Delegate Source 3
Other TagsTransformationTransformationOptimizationOptimizationBiolisticSimultaneousSelectionSelectionSelectionOther Tagsrather 2rather 3rather 4rather 5rather 6rather 7rather 8rather 9rather 10year 2year 3year 4year 5year 6year 7year 8year 9year 10overcome 2overcome 3overcome 4overcome 5overcome 6overcome 7overcome 8overcome 9overcome 10remedy 2remedy 3remedy 4remedy 5electricity 2electricity 3promotes 2promotes 3promotes 4promotes 5silence 2silence 3competition 2competition 3competition 4